A new type of scan to look for live brain tumor after radiation
Original title: Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test in people to see if the scan works.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a scan that may show whether a high grade brain tumor is still active after radiation.
Who this trial is for. This study is for children and adults with high grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary who have finished radiation. Some also had the drug temozolomide. It tests a PET/MRI scan that uses two tracers to look for live tumor.
Where it stands. The trial has not reported results. It is checking whether this scan can show live tumor after radiation. People in the study are followed with their usual scans for up to 2 years. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If the scan works, care teams may get a clearer picture of what is left after radiation. Someone who fits might ask their care team about it.
What it doesn't mean: This does not mean the scan is proven. A trial is a test, not care that is known to work. Being in one does not promise any benefit. This is a scan, not a treatment, and it is not a cure or a promise of one.
Source: ClinicalTrials.gov, August 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.